Search bioRxivSearch

Biology subjects

Jahn, K.

Publications and source records attributed to Jahn, K..

3 recordsLinked to original sources

SCIΦ: Single-cell mutation identification via phylogenetic inference

Understanding the evolution of cancer is important for the development of appropriate cancer therapies. The task is challenging because tumors evolve as heterogeneous cell populations with an unknown number of genetically distinct subclones of varying frequencies. Conventional approaches based on bulk sequencing are limited in addressing this challenge as clones cannot be observed directly. Single-cell sequencing holds the promise of resolving the heterogeneity of tumors; however, it has its own challenges including elevated error rates, allelic dropout, and uneven coverage. Here, we develop a new approach to mutation detection in individual tumor cells by leveraging the evolutionary relationship among cells. Our method, called SCI{Phi}, jointly calls mutations in individual cells and estimates the tumor phylogeny among these cells. Employing a Markov Chain Monte Carlo scheme we robustly account for the various sources of noise in single-cell sequencing data. Our approach enables us to reliably call mutations in each single cell even in experiments with high dropout rates and missing data. We show that SCI{Phi} outperforms existing methods on simulated data and applied it to different real-world datasets, namely a whole exome breast cancer as well as a panel acute lymphoblastic leukemia dataset. Availability: https://github.com/cbg-ethz/SCIPhI

bioinformatics

Integrative inference of subclonal tumour evolution from single-cell and bulk sequencing data

Understanding the evolutionary history and subclonal composition of a tumour represents one of the key challenges in overcoming treatment failure due to resistant cell populations. Most of the current data on tumour genetics stems from short read bulk sequencing data. While this type of data is characterised by low sequencing noise and cost, it consists of aggregate measurements across a large number of cells. It is therefore of limited use for the accurate detection of the distinct cellular populations present in a tumour and the unambiguous inference of their evolutionary relationships. Single-cell DNA sequencing instead provides data of the highest resolution for studying intra-tumour heterogeneity and evolution, but is characterised by higher sequencing costs and elevated noise rates. In this work, we develop the first computational approach that infers trees of tumour evolution from combined single-cell and bulk sequencing data. Using a comprehensive set of simulated data, we show that our approach systematically outperforms existing methods with respect to tree reconstruction accuracy and subclone identification. High fidelity reconstructions are obtained even with a modest number of single cells. We also show that combining single-cell and bulk sequencing data provides more realistic mutation histories for real tumours.

bioinformatics

A statistical test on single-cell data reveals widespread recurrent mutations in tumor evolution

The infinite sites assumption, which states that every genomic position mutates at most once over the lifetime of a tumor, is central to current approaches for reconstructing mutation histories of tumors, but has never been tested explicitly. We developed a rigorous statistical framework to test the assumption with single-cell sequencing data. The framework accounts for the high noise and contamination present in such data. We found strong evidence for recurrent mutations at the same site in 8 out of 9 single-cell sequencing datasets from human tumors. Six cases involved the loss of earlier mutations, five of which occurred at sites unaffected by large scale genomic deletions. Two cases exhibited parallel mutation, including the dataset with the strongest evidence of recurrence. Our results refute the general validity of the infinite sites assumption and indicate that more complex models are needed to adequately quantify intra-tumor heterogeneity.

cancer biology